News Center
Lizhu Pharmaceutical Factory has obtained CNAS accreditation certificate
Release time:
2017-01-02
Recently, the testing center of Livzon Group's Livzon Pharmaceutical Factory received the recognition decision and laboratory accreditation certificate issued by the China National Accreditation Service for Conformity Assessment (CNAS). This is a major piece of good news at the beginning of the new year! It is a tangible report that can bring added value effects to enterprise certification, enterprise brand, enterprise quality, R&D, and enterprise management! The authority of CNAS: The China National Accreditation Service for Conformity Assessment is authorized by the National Certification and Accreditation Administration (CNCA) to implement the national accreditation system for conformity assessment. The issuance of the laboratory accreditation certificate to the Livzon Pharmaceutical Factory testing center by CNAS is
Recently, the testing center of Livzon Group's Livzon Pharmaceutical Factory received the accreditation decision and laboratory accreditation certificate issued by the China National Accreditation Service for Conformity Assessment (CNAS). This is a major piece of good news at the beginning of the new year! It is a tangible report that can bring added value to enterprise certification, brand, quality, research and development, and business management!
The authority of CNAS: The China National Accreditation Service for Conformity Assessment is authorized by the National Certification and Accreditation Administration (CNCA) to implement the national accreditation system for conformity assessment. The issuance of the laboratory accreditation certificate to the testing center of Livzon Pharmaceutical Factory by CNAS is a strong proof of the social credibility and core competitiveness of Livzon Group's products by a national authority. Another significance is that Livzon Group is one of the few domestic pharmaceutical companies that have passed CNAS accreditation, and Livzon Pharmaceutical Factory is also the first secondary enterprise within Livzon Group to pass CNAS accreditation. It also indicates that Livzon Group's Livzon Pharmaceutical Factory is not only a company that meets GMP requirements but also a company that meets the national laboratory accreditation (CNAS) of the ISO/IEC 17025 system. Through CNAS accreditation, it also proves that the testing center of Livzon Group's Livzon Pharmaceutical Factory has a high level of testing capability, operating according to the CNAS system and implementing capability verification, uncertainty analysis, traceability, quality supervision, personnel comparison, management review, etc., effectively improving the laboratory's operational norms, data accuracy, and report authority.
The extension of CNAS: Through national laboratory accreditation (CNAS), it lays a solid foundation for Livzon Pharmaceutical Factory to obtain authoritative testing report mutual recognition for international certifications such as WHO, EU, and FDA.As we all know: CNAS is a member of the mutual recognition agreement of the International Laboratory Accreditation Cooperation (ILAC) and the Asia-Pacific Laboratory Accreditation Cooperation (APLAC). Through CNAS accreditation, it can issue authoritative testing reports that are legal, effective, and mutually recognized in both international and domestic markets.
The driving force of CNAS: Through CNAS accreditation, it can issue testing reports that are authorized by the National Accreditation Committee to use the CNAS and ILAC-MAR internationally recognized laboratory accreditation logos, which is beneficial for Livzon Group to gain an advantage in the bidding procurement of pharmaceuticals in some provinces and cities in China, promoting the market sales of the group's products; this will strongly promote the enterprise's operations to a new level and achieve rapid development.
The added value of CNAS: Through CNAS accreditation, Livzon Group can apply for funding for key laboratory research and development centers based on actual conditions, enhancing the visibility of Livzon Group's research strength.
Related Information